NMNAT2 antibody
Quick Overview for NMNAT2 antibody (ABIN1169224)
Target
See all NMNAT2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- anti-NMNAT2 (human), mAb (Nady-1)
-
Specificity
- Recognizes human NMNAT2.
-
Characteristics
- Monoclonal Antibody. Recognizes human NMNAT2. Isotype: Mouse IgG1kappa. Clone: Nady-1. Applications: ELISA, IHC, WB. Liquid. 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives. NMNAT2 catalyzes the formation of NAD+ from nicotinamide mononucleotide (NMN) and ATP. Can also use the deamidated form nicotinic acid mononucleotide (NaMN) as a substrate but with lower efficiency. Also catalyzes the reverse reaction, i.e. the pyrophosphorolytic cleavage of NAD+. Highly expressed in brain, in particular in cerebrum, cerebellum, occipital lobe, frontal lobe, temporal lobe and putamen. Also found in the heart, skeletal muscle, pancreas and islets of Langerhans. Has been shown to correlate with Alzheimer's disease in APPswe/PS1dE9 transgenic mice and delayed wallerian degeneration in cultured superior cervical ganglia (SCGs) from morphological changes, microtubule destruction and neurofilament degradation.
-
Sterility
- 0.2 μm filtered
-
Immunogen
- Recombinant human NMNAT2.
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.2μm-filtered solution in PBS, pH 7.4.
-
Preservative
- Without preservative
-
Handling Advice
- After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
+4°C
-20°C
Stable for at least 1 year after receipt when stored at -20°C.
-
Expiry Date
- 12 months
-
-
- NMNAT2 (Nicotinamide Nucleotide Adenylyltransferase 2 (NMNAT2))
-
Alternative Name
- NMNAT2
-
Background
-
Alternate Names/Synonyms: Nicotinamide Mononucleotide Adenylyltransferase 2, NMN Adenylyltransferase 2, NaMN Adenylyltransferase 2
Product Description: NMNAT2 catalyzes the formation of NAD+ from nicotinamide mononucleotide (NMN) and ATP. Can also use the deamidated form nicotinic acid mononucleotide (NaMN) as a substrate but with lower efficiency. Also catalyzes the reverse reaction, i.e. the pyrophosphorolytic cleavage of NAD+. Highly expressed in brain, in particular in cerebrum, cerebellum, occipital lobe, frontal lobe, temporal lobe and putamen. Also found in the heart, skeletal muscle, pancreas and islets of Langerhans. Has been shown to correlate with Alzheimer's disease in APPswe/PS1dE9 transgenic mice and delayed wallerian degeneration in cultured superior cervical ganglia (SCGs) from morphological changes, microtubule destruction and neurofilament degradation.
-
UniProt
- Q9BZQ4
Target
-